FDA rejects MDMA therapy for PTSD

By Becker's Hospital Review | Healthcare News & Analysis in Becker's Hospital Review, Channels, Featured, ROOT, Static
August 12, 2024

The FDA has rejected pharmaceutical midomafetamine (MDMA) drug therapy for the treatment of PTSD.

Read the full post on Becker's Hospital Review | Healthcare News & Analysis

Becker's Hospital Review | Healthcare News & Analysis